Stock detail
Alnylam Pharmaceuticals, Inc (ALNY) stock price, chart, and key data
View Alnylam Pharmaceuticals, Inc stock price, chart movement, and headline metrics on Woodstock's stock detail page.
Stock detail
Alnylam Pharmaceuticals, Inc
ALNY · XNAS
$227.66
0.00%
$0.00
Overnight $231.70 (+1.77%)
Key metrics
52-week range
$9.00 - $7.00
Close price
$227.66
Market cap
$30B
P/E ratio
188.15
Beta
0.86
About the company
Alnylam Pharmaceuticals, Inc
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list.
Analyst rating summary
A current read on analyst sentiment from the insight feed.
Mean target
$365
19
Buy
/ 23
Recent calls
10/21/2026
TD Cowen
Ritu Baral
Buy · Price target $482
10/16/2026
UBS
Joon Lee
Buy · Price target $354
10/14/2026
Wells Fargo
Derek Archila
Hold · Price target $253
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app